Harnessing Stem Cell–Like T Cells to Better Fight Cancer

Better understanding the CD8+ T cells already present in tumors could be key to making immunotherapies work for more patients.

Written byDaniel E. Speiser and Werner Held
| 15 min read

Register for free to listen to this article
Listen with Speechify
0:00
15:00
Share

ABOVE: © science source, KEITH CHAMBERS

Tumors are relatively easy to treat if they stay put, but cancer cells become more deadly when they disseminate to distant parts of the body. Surgery and local irradiation are not well suited for treating cancers that have spread and formed metastases at multiple body locations, and most types of metastatic cancer become progressively resistant to treatment with chemotherapeutic drugs or small molecule inhibitors that aim to block tumor growth.

The development of immunotherapy, a treatment that does not act directly on the tumor but rather stimulates the immune system to more effectively defend the whole body, has improved prognoses for some types of metastatic cancer. About 50 years ago, researchers found that one component of the immune system, CD8+ T cells, have the remarkable potential to detect and kill cancer cells. Groundbreaking research on melanoma, an aggressive type of skin cancer, and later ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

July/August 2020

Life During a Pandemic

Understanding the virus is just the beginning

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform